Digital Life Platform from ICarbonX helps clinicians in early screening, preventive intervention, prognosis tracking, and precision medicine in various diseases including cancer and other disorders such as hypertension, cardiovascular diseases, and diabetes.


Clinicians can comprehensively profile cancer patients and to cross-validate biomedical markers between multiple molecular levels in order to distinguish truly meaningful markers from spurious signals and aid in accurate cancer treatment. Equally helps clinical researchers and doctors to understand the complications of chronic disorders and to position their patients for effective treatment through precision medicine. For example, an estimated 5%-10% of 463 million adult diabetes patients were misdiagnosed as having type 2 instead of type 1, and hence mistreated until further symptoms developed.